celecoxib has been researched along with atosiban in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chyczewski, L; Kowalczuk, O; Kuć, P; Laudański, P; Laudański, T | 1 |
2 other study(ies) available for celecoxib and atosiban
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Expression of selected genes in preterm premature rupture of fetal membranes.
Topics: Adult; Calcium Channel Blockers; Calcium Channels, L-Type; Celecoxib; Cyclooxygenase 2 Inhibitors; Dinoprostone; Endometritis; Female; Fetal Membranes, Premature Rupture; Gene Expression Profiling; Gene Expression Regulation, Developmental; Humans; Nifedipine; Obstetric Labor, Premature; Oxytocics; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Premature Birth; Pyrazoles; RNA, Messenger; Sulfonamides; Term Birth; Tocolytic Agents; Vasotocin | 2012 |